Clinical pharmacology of labetalol.
- 1 January 1979
- journal article
- review article
- Vol. 8, 89S-93S
Abstract
1 The clinical pharmacology of labetalol has been evaluated using pharmacological and physiological test methods.This publication has 27 references indexed in Scilit:
- The second Lilly Prize Lecture, University of Newcastle, July 1977. beta‐Adrenergic receptor blockade in hypertension, past, present and future.British Journal of Clinical Pharmacology, 1978
- Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patientsAmerican Heart Journal, 1977
- Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.Published by Wiley ,1977
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Pharmacological basis for antihypertensive effects of intravenous labetalol.Heart, 1977
- Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.BMJ, 1975
- New Approach to Assessment of Cardioselectivity of Beta-blocking DrugsBMJ, 1974
- Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.Heart, 1974
- ALPHA AND BETA ADRENERGIC BLOCKADE IN HYPERTENSIONThe Lancet, 1972
- Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytomaThe American Journal of Cardiology, 1966